Disease details

Clinical trials : 3,340 / Drugs : 2,163 - (DrugBank : 383) / Drug target genes : 241 - Drug target pathways : 238

1 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02035514 (ClinicalTrials.gov)	December 2013	17/12/2013	Phase I-II Clinical Trial With Autologous Bone Marrow Derived Mesenchymal Stem Cells for the Therapy of Multiple Sclerosis	Phase I-II Clinical Trial With Autologous Bone Marrow Derived Mesenchymal Stem Cells for the Therapy of Multiple Sclerosis	Relapsing Remitting Multiple Sclerosis (RRMS)	Biological: Bone marrow autologous mesenchymal stem cells transplantation	Germans Trias i Pujol Hospital	Ministerio de Sanidad, Servicios Sociales e Igualdad	Completed	18 Years	50 Years	Both	9	Phase 1/Phase 2	Spain